Concepedia

Brenda K. Eustace

BK

Statistics

Publications

16

Citations

5K

H-Index

15

Active since

2000

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Tufts University

Harvard University

Assistance Publique – Hôpitaux de Paris

Cornell University

Brenda K. Eustace is an author at Vertex Pharmaceuticals (United States) specializing in medicine, cell biology, and cellular biochemistry.

Top concepts

Publications per year

2000–2020

16

Publications

16

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

Haydar Frangoul, David Altshuler, Maria Domenica Cappellini et al. · New England Journal of Medicine · 2020 · 1.7K citations · Full text

A Mutation in the LDL Receptor–Related Protein 5 Gene Results in the Autosomal Dominant High–Bone-Mass Trait

Randall D. Little, Colleen Folz, Susan P. Manning et al. · The American Journal of Human Genetics · 2002 · 1.3K citations · Full text

, , +4

Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness

Brenda K. Eustace, Takashi Sakurai, Jean K. Stewart et al. · Nature Cell Biology · 2004 · 587 citations

, , +14

CD155/PVR plays a key role in cell motility during tumor cell invasion and migration

Kevin E. Sloan, Brenda K. Eustace, Jean K. Stewart et al. · BMC Cancer · 2004 · 235 citations · Full text

Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970

Amy B. Hall, Dave Newsome, Yuxin Wang et al. · Oncotarget · 2014 · 189 citations · Full text

1–5 of 16